Daily Archives: October 6, 2022

Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort.

Posted on October 6, 2022 by admin

an de Berg TW, Mulder MMG, Alnima T, Nagy M, van Oerle R, Beckers EAM, Hackeng TM, Hulshof AM, Sels JEM, Henskens YMC, van der Horst ICC, Ten Cate H, Spronk HMH, van Bussel BCT; MaastrICCht Collaborators. Front Cardiovasc Med. … Continue reading →

Posted in publications | Leave a comment

Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trial.

Posted on October 6, 2022 by admin

Willems LH, Thijssen DHJ, Groh LA, Kooijman NI, Ten Cate H, Spronk HMH, Donders ART, van der Vijver-Coppen RJ, van Hoek F, Nagy M, Reijnen MMPJ, Warlé MC. Front Cardiovasc Med. 2022 Oct 6;9:979819. PMID: 36277757 Objective: Dual pathway inhibition … Continue reading →

Posted in publications | Leave a comment